What’s it take to recruit a top drug development exec out of Gilead? Stock options help, a lot

What’s it take to recruit a top drug development exec out of Gilead? Stock options help, a lot

Source: 
Endpoints
snippet: 

For the growing ranks of public biotechs, stock options are proving an attractive allure for new executive recruits coming out of the top ranks of the world’s big biopharma companies.